Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Cognetivity Neurosciences Ltd
C.CGN
Alternate Symbol(s):
CGNSF
Cognetivity Neurosciences Ltd. is a Canada-based technology company. The Company has developed a cognitive testing platform, the Integrated Cognitive Assessment (ICA), for use in medical and commercial environments and other neurological conditions. The Company’s CognICA uses artificial intelligence and machine learning technology to test the performance of large areas of the brain to help...
detect early signs of cognitive dysfunction. It is also focused on developing the ICA for home use, for the remote monitoring of patient’s progress under treatment regimens and for general home healthcare check-ups. CognICA is available for clinical use in the United States, United Kingdom, Europe, Canada and the Middle East. Its subsidiaries include Cognetivity Ltd. and Cognetivity FZ-LLC.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (CSE:CGN)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
Next
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Feb 23, 2023 8:31am
New Press Release - Cognetivity Neurosciences Announces Commercial Deployment at Leading Psychiatry and Neurology Centre in UAE
Latest Agreement Signals Continued, Rapid Commercial Growth in Middle East RegionVancouver, British Columbia--(Newsfile Corp. - February 23, 2023) - Cognetivity Neurosciences Ltd. (CSE: CGN) (OTCQB: CGNSF) (FSE: 1UB) (the "Company" or "Cognetivity"),a technology company that has created a unique...
read article.
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Feb 22, 2023 8:31am
New Press Release - Cognetivity Announces Further Scientific Evidence of its AI-Powered CognICA(TM) Platform's Ability to Detect and Monitor Cognitive Impairment in Patients With Multiple Sclerosis
Peer-reviewed article demonstrates effectiveness of company's technology in major disease area with global application for the detection and monitoring of diseaseVancouver, British Columbia--(Newsfile Corp. - February 22, 2023) - Cognetivity Neurosciences Ltd. (CSE: CGN) (FSE: 1UB) (OTCQB: CGNSF)...
read article.
QMET has 11 claims and 633 hectares Property in Ville-Marie, Quebec Hydrogen Camp
posted Nov 25, 2024 9:00am by
Q Precious & Battery Metals Corp.
-
|
The Company is pleased to discover that their Lorrain claims are now within the new and exciting exploration for hydrogen in the Ville-Marie, Lorrainville and Béarn region of Quebec. The region has undergone a claim staking rush following the ...read more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Feb 14, 2023 8:31am
New Press Release - Cognetivity Neurosciences Releases Latest Version of AI-powered Brain Health Assessment Platform
With global interest in AI at an all-time high, latest update to Cognetivity's flagship medical device affirms company's sustained commitment to being at the forefront of AI in healthcareVancouver, British Columbia--(Newsfile Corp. - February 14, 2023) - Cognetivity Neurosciences Ltd. (CSE: CGN) ...
read article.
(8)
•••
drd8
X
View Profile
View Bullboard History
Post by
drd8
on Feb 10, 2023 11:47am
transforming alzheimers/dementia with AI
all you need to do is read any araticle and see the significant upside to this company https://cognetivity.com/resources/?type=news
(56)
•••
jolew32
X
View Profile
View Bullboard History
Post by
jolew32
on Feb 10, 2023 8:44am
Sky's the limit for CGN & CognICA!
Not only will Eisai & Biogen need CGN's digital diagnostic tool CognICA to monitor regularly existing Alzheimer's patients taking their new Alzheimer's drug Lecanemab, but they will
...more
(56)
•••
jolew32
X
View Profile
View Bullboard History
Comment by
jolew32
on Feb 10, 2023 8:39am
RE:Very important read for CGN shareholders
Not only will Eisai @ Biogen need CGN@s digital diagnostic tool CognICA to monitor regularly existing Alzheimer@s patients taking their new Alzheimer@s drug Lecanemab, but they will also need CognICA
...more
(56)
•••
jolew32
X
View Profile
View Bullboard History
Comment by
jolew32
on Feb 10, 2023 8:37am
RE:Very important read for CGN shareholders
Not only will Eisai & Biogen need CGN's digital diagnostic tool CognICA to monitor regularly existing Alzheimer's patients taking their new Alzheimer's drug Lecanemab, but they will
...more
(56)
•••
jolew32
X
View Profile
View Bullboard History
Post by
jolew32
on Feb 09, 2023 12:52pm
Very important read for CGN shareholders
https://www-newyorker-com.cdn.ampproject.org/v/s/www.newyorker.com/science/annals-of-medicine/the-promise-of-a-new-alzheimers-drug/amp?amp_gsa=1&_js_v=a9&usqp=mq331AQIKAGwASCAAgM%3D#amp_tf
...more
(56)
•••
jolew32
X
View Profile
View Bullboard History
Post by
jolew32
on Jan 24, 2023 9:33am
Great news!!!
https://ceo.ca/@newsfile/cognetivity-neurosciences-cognica-platform-successfully
(56)
•••
jolew32
X
View Profile
View Bullboard History
Post by
jolew32
on Jan 13, 2023 8:55am
Biogen looking to get new Alzheimer's drug Lecanemab approve
Eisai & Biogen applied on Jan 10, 2023 to get Lecanemab approved in Europe. They got fast track approval in the U.S. on Jan 6, 2023 and applied to China for approval on Dec 22, 2022. E&B are
...more
(56)
•••
jolew32
X
View Profile
View Bullboard History
Post by
jolew32
on Jan 06, 2023 3:41pm
Biogen FDA approval for latest Alzheimer's drug
Unfortunately Roche's Alzheimer's drug didn't get approved even though Roche was looking into using CognICA to test the general population for early Alzheimer's patients who would
...more
(56)
•••
jolew32
X
View Profile
View Bullboard History
Post by
jolew32
on Nov 07, 2022 9:38am
CGN to present to Roche's Alzheimer's division
https://ceo.ca/@newsfile/cognetivity-neurosciences-selected-to-present-to-roche
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Oct 07, 2022 6:01pm
New Press Release - Cognetivity Neurosciences Announces Private Placement of Convertible Preferred Shares
Vancouver, British Columbia--(Newsfile Corp. - October 7, 2022) - Cognetivity Neurosciences Ltd. (CSE: CGN) (OTCQB: CGNSF) (FSE: 1UB) (the "Company" or "Cognetivity") is pleased to announce, that it intends to complete a non-brokered private placement of up to 10,344,828 convertible preferred...
read article.
(56)
•••
jolew32
X
View Profile
View Bullboard History
Post by
jolew32
on Sep 20, 2022 9:35am
Commercial Pilot with Large US Healthcare Provider
https://ceo.ca/@newsfile/cognetivity-neurosciences-announces-commercial-pilot
(433)
•••
AwareInvestor
X
View Profile
View Bullboard History
Post by
AwareInvestor
on Sep 13, 2022 8:53am
Cognetivity Sees Its Cognitive Tool Used In Clinical Study F
While it may have been initially developed for the early detection of Alzheimer’s disease or other cognitive impairments in patients, it appears that Cognetivity Neurosciences’ flagship product
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Options Trading for Retiring: Key Strategies in Balancing Retirement Income
One Property, One Focus on Advancing this Gold Project in Ontario